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Abstract
Background: With the current influenza A H1N1 pandemic (H1N1pdm), it is extremely important that clinicians can quickly
and accurately identify influenza cases.
Methodology/Principal Findings: To investigate the performance of the QuickVue Influenza A+B rapid test, we conducted
a prospective study of the diagnostic accuracy of the QuickVue Influenza A+B test compared to real-time reverse
transcriptase-polymerase chain reaction (RT-PCR) for influenza A H1N1pdm in Nicaraguan children aged 2 to 14 years. Rapid
test sensitivity and specificity compared to real-time RT-PCR were 64.1% (95% CI 53.5, 73.9) and 98.3% (95.0, 99.6),
respectively. Agreement between the two tests was 86.4% (95% CI 81.7, 90.3), and kappa was calculated to be 0.67 (95% CI
0.56, 0.76). Performance of the rapid test varied by day of presentation, with a sensitivity of 41.7% (95% CI 22.1, 63.4) for
samples from children presenting on the day of symptom onset and a sensitivity of 72.1% (95% CI 59.9, 82.3) for samples
from children presenting one or more days post-symptom onset.
Conclusions/Significance: We found that the rapid test performed with moderate sensitivity and high specificity. Test
performance varied by day of onset, with lower sensitivity on the day of symptom onset.
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Introduction
With the current H1N1 influenza pandemic and potential
shortage of antiviral medications, especially in developing
countries, it is important that physicians rapidly and accurately
diagnose influenza A H1N1 pandemic (H1N1pdm) cases. Rapid
point-of-care diagnostic tests that can be performed in under 15
minutes provide a significant time advantage over other
laboratory-intensive influenza testing methods. Rapid tests aid in
clinical decision-making, reduce inappropriate antibiotic use, and
decrease emergency department visit time [1,2,3]. Additionally,
they allow for testing in resource-limited settings where equipment,
reagents, and highly trained laboratory personnel are not always
available.
The performance of rapid tests in detecting seasonal influenza A
and B has been reported in numerous studies [1,4,5,6,7,8]. Rapid
tests have been shown to have lower accuracy than the reference
tests of viral culture and reverse transcriptase polymerase chain
reaction (RT-PCR), with reported sensitivities of rapid tests
ranging from 27% to 90% and specificities ranging from 86% to
100% [1,4,5,6,7,8]. The reported performance of rapid tests for
pandemic influenza A H1N1 has varied, with sensitivities ranging
from 10% to 75% [9,10,11,12,13,14].
The objective of this study was to investigate the diagnostic
accuracy of the QuickVue Influenza A+B rapid test for influenza
A H1N1pdm compared to real-time RT-PCR in children in
Nicaragua.
Methods
Ethics Statement
This study was approved by the institutional review boards at
the Nicaraguan Ministry of Health and the University of
California, Berkeley. Written informed consent was obtained from
the parents or guardians of all participants, and assent was
obtained from those participants aged 6 and over.
Study Design
The Nicaraguan Influenza Cohort Study is an ongoing
prospective, community-based cohort study of influenza in
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children were recruited into the study through house-to-house
visits in neighborhoods surrounding the study health center,
Health Center So ´crates Flores Vivas (HCSFV). Each year, new 2-
year-old participants are enrolled. At enrollment, parents agree to
bring their child to study physicians at first sign of illness. Data
from all medical visits are collected onto standardized study
instruments. The case definition for testing used in this analysis
was any participant with fever or history of fever and with cough
or sore throat of ,5 days duration. A nasal respiratory specimen
was collected using the swab provided in the kit for rapid testing.
A second sample, consisting of nasal and throat Dacron swabs,
was collected simultaneously for use in real-time RT-PCR testing.
The rapid tests were performed immediately on-site at the
HCSFV clinical laboratory according to manufacturer’s instruc-
tions. The clinical laboratory staff had previous experience
collecting nasal and throat swabs. Clinical laboratory staff
received an additional 1.5 hours of training on influenza, the
principles of the rapid test, and how to collect samples for and
perform the rapid test.
Samples for RT-PCR testing were kept at 4uC and transported to
the National Virology Laboratory at the Ministry of Health within
72 hours. QiaAmp Viral RNA isolation kits were used to extract
RNA from the viral transport media. Real-time RT-PCR was
performed according to standard protocols developed by the Centers
forDiseaseControlandPrevention(CDC)[15]andusingprobesand
primers provided by the CDC. The complete protocol, along with
primer and probe sequences, can be found online at www.who.int/
csr/resources/publications/swineflu/CDCrealtimeRTPCRprotocol_
20090428.pdf. All RT-PCR testing was performed in the Nicaraguan
National Virology Laboratory by personnel trained to perform the
protocol by the CDC. Personnel performing RT-PCR assays were
blinded both to the rapid test results and to the clinical presentation of
the patients.
Outcome measures of this study are sensitivity, specificity,
positive predictive value (PPV), and negative predictive value
(NPV). Test agreement was calculated using the kappa statistic.
Sub-analyses were performed to examine rapid test performance
in children meeting the CDC definition of influenza-like illness
(fever$37.8uC with cough or sore throat) and to analyze the
performance of the rapid test by day after symptom onset. To
investigate any effect of including the samples from 13 children
who contributed two samples a subanalysis limited to the first
sample contributed by a participant was performed. No significant
difference was found when second samples were excluded, and
thus all results reported in this study include the second samples.
All statistical analyses were performed using STATA 10.1
(StataCorp, College Station, Texas).
Results
Two hundred and sixty-seven samples were collected from 254
cohort participants meeting the case definition; thirteen children
contributed a sample from two separate illness episodes. The
participants were aged 2 to 14 years (median 6.9 years). Of the 267
cases, 72 (27%) presented on the day of developing symptoms, 146
(55%) presented 1 day after onset of symptoms, 22 (8%) presented 2
days post-symptom onset, and 27 (10%) presented 3 or more days
after developing symptoms. One hundred and thirty six cases met
the CDC definition of influenza-like illness. Two samples tested
positive for seasonal influenza by RT-PCR and were excluded from
theanalysis.Intotal,92(35%)samples testedpositiveforH1N1pdm
by RT-PCR. The rapid test detected 59 (64%) of the RT-PCR
influenza-positive samples. The sensitivity and specificity of the
rapid test compared to RT-PCR were 64.1% (95% CI 53.5, 73.9)
and 98.3% (95.0, 99.6), respectively (Table 1). Agreement between
the two tests was 86.4% (95% CI 81.7, 90.3) and kappa was
calculated to be 0.67 (95% CI 0.56, 0.76). Sub-analysis of the 136
cases that met the CDC definition of influenza-like-illness did not
result in significant changes in test performance, nor did including
the two seasonal influenza cases (data not shown).
Sub-analyses examining test performance by day of onset were
performed. Among children who presented on the day of symptom
onset, rapid test sensitivity and specificity compared to RT-PCR
were 41.7% (95% CI 22.1, 63.4) and 97.9% (95% CI 88.9, 99.9).
Testagreementwas79.2%(95%CI68.0,87.8),and kappawas0.45
(95% CI 0.19, 0.64). Diagnostic accuracy of the rapid test was
higher for children presenting $1 days after symptom onset, with a
sensitivity of 72.1% (95% CI 59.9, 82.3) and a specificity of 98.4%
(95% CI 94.3, 99.8). Agreement between the tests was 89.1% (95%
CI 83.8, 93.1), and kappa was 0.75 (95% CI 0.62, 0.83).
Discussion
We found that the QuickVue Influenza A+B rapid test
performed moderately well, with an intermediate sensitivity and
a high specificity in comparison to the CDC real-time RT-PCR
assay for influenza A H1N1pdm. Furthermore, we found that test
performance varied depending on how many days after symptom
onset the patient presented at the clinic.
Several studies have been published on the performance of the
QuickVue Influenza A+B rapid test in detecting influenza A
H1N1pdm, with reported sensitivities ranging from 51 to 75%
[11,12,13,14]. Our sensitivity estimate of 64.1% falls within the
range of previously reported sensitivities and is very similar to the
estimate of a sensitivity of 62.7% from the Suntarattiwong et al.
study in Thai children [11]. In this same Nicaraguan cohort, we
have previously evaluated the performance of the rapid test for
Table 1. Performance of the QuickVue Influenza A+B Rapid Test for Influenza A H1N1pdm, Managua, Nicaragua, 2009.
Number of
Positive
Samples Sensitivity Specificity Positive Predictive Value Negative Predictive Value
(%) (%) (95% CI) (%) (95% CI) (%) (95% CI) (%) (95% CI)
All cases 92 (35) 64.1 (53.5, 73.9) 98.3 (95.0, 99.6) 95.2 (86.5, 99.0) 83.7 (77.9, 88.5)
Day of symptom onset 24 (33) 41.7 (22.1, 63.4) 97.9 (88.9, 99.9) 90.9 (58.7, 99.8) 77.0 (64.5, 86.8)
$1 day post symptom
onset
68 (35) 72.1 (59.9, 82.3) 98.4 (94.3, 99.8) 96.1 (86.5, 99.5) 86.6 (79.9, 91.7)
doi:10.1371/journal.pone.0010364.t001
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analysis, the rapid test was found to have a sensitivity of 65.2%
(95% CI 58.5, 71.4) and a specificity of 99.1% (95% CI 98.3, 99.6)
which is very similar to the results found for H1N1pdm in this
study [16]. Likewise, in our previous study, we found a
significantly lower sensitivity of the rapid test for seasonal influenza
in samples collected on the day of symptom onset compared to
samples collected one or two days following symptom onset.
In this study, we used separate samples for the rapid test and the
RT-PCR. Although this method could result in some discordant
results, we do not feel that this is a limitation of the study. Rather,
in order to accurately assess the performance of the rapid test, the
swab provided with the test and recommended by the manufac-
turer must be used. Likewise, for RT-PCR the current standard in
Nicaragua and many countries is a combined nasal and throat
swab. Furthermore, the rapid test swab is unusable for other
diagnostic purposes once the swab is inserted into the testing
solution. Thus, by adhering to the current, recommended sample
collection procedures for each test respectively, this comparison
allows us to assess the diagnostic accuracy of the QuickVue rapid
test compared to RT-PCR in real-world conditions. In addition,
the use of the two different sample types may explain the specificity
of less than 100% observed in the study.
One limitation of this study is that families participating in the
Nicaraguan Influenza Cohort Study are encouraged to bring their
child in for medical care at the very first sign of illness, which
results in a significant proportion of children presenting on the day
of symptom onset in this study (27%). Since we found that rapid
test performance was lower on the day of symptom onset, using
this population may result in a conservative overall estimate of the
rapid test performance. To address this issue, we performed sub-
analyses by day of onset. For the general clinical population, the
performance of the test may be closer to our estimate of a
sensitivity of 72.1% and specificity of 98.4%, which we calculated
for children who presented one or more days after symptom onset.
Our findings support that the QuickVue rapid test performs
moderately well in the detection of influenza A H1N1pdm. Of
note, we found that the test performs with low sensitivity on the
day of symptom onset.
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